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Anticancer Activities of Plant Secondary Metabolites: Rice
Callus Suspension Culture as a New Paradigm
Wusirika RAMAKRISHNA1, #, Anuradha KUMARI1, #, Nafeesa RAHMAN2, Pallavi MANDAVE3
(1Department of Biochemistry, Central University of Punjab, Bathinda, Punjab 151001, India; 2Department of Biological Sciences,
Michigan Technological University, 1400 Townsend Drive Houghton, Michigan 49931, USA; 3Interactive Research School for
Health Affairs, Bharati Vidyapeeth, Pune, Maharashtra 411043, India; #These authors contributed equally to this work)

Abstract: Plant natural products including alkaloids, polyphenols, terpenoids and flavonoids have been
reported to exert anticancer activity by targeting various metabolic pathways. The biological pathways
regulated by plant products can serve as novel drug targets. Plant natural compounds or their derivatives
used for cancer treatment and some novel plant-based compounds which are used in clinical trials were
discussed. Callus suspension culture with secondary metabolites can provide a continuous source of
plant pharmaceuticals without time and space limitations. Previous research has shown that rice callus
suspension culture can kill > 95% cancer cells with no significant effect on the growth of normal cells. The
role of candidate genes and metabolites which are likely to be involved in the process and their potential
to serve as anticancer and anti-inflammatory agents were discussed. Large scale production of plant
callus suspension culture and its constituents can be achieved using elicitors which enhance specific
secondary metabolites combined with bioprocess technology.
Key words: plant metabolite; cancer metabolism; rice callus suspension culture; cytotoxicity; anticancer
agent

Cancer is the leading cause of mortality after
cardiovascular diseases. Cancer incidence increases
with age with > 75% new cases among the age group
of 55 years and above (White et al, 2014). Numbers of
estimated cancer cases in USA in 2019 are 268 600,
228 150, 174 650, 145 600 and 73 820 for breast, lung,
prostate, colorectal and renal cancers, respectively
(American Cancer Society, 2019). Numbers of estimated
deaths due to cancer in USA are 142 670, 51 020, 41 760,
31 620 and 14 770 for lung, colorectal, breast, prostate
and renal cancers, respectively. Cancer is an inherited
or sporadic complex genetic disease due to various
modifications in gene expression (Wishart, 2015).
These modifications can be in the forms of point
mutations, insertions, deletions, transpositions and
translocation resulting in uncontrolled proliferation, which

is the hallmark of cancer.
Proto-oncogenes and tumor suppressor genes are
the two categories of genes that conventionally undergo
alterations (Lee and Muller, 2010). In cancer, the
expression of tumor suppressor genes is inhibited, and
proto-oncogenes are upregulated by various mutations.
These pro-oncogenic alterations help the mutated cell
to bypass every checkpoint of cell division, ultimately
invading and spreading to the neighboring tissues.
Metastasis is initiated by the formation of new blood
vessels from existing vessels called angiogenesis.
Various factors responsible for the mutation of normal
cell to cancer cell include exposure to asbestos, tobacco,
drugs, radiation and oncogenic viruses, ultimately
resulting in an alteration in the genetic makeup of the
cell. In comparison to normal cells, cancer cells exhibit
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nuclear pleomorphisms, chromosomal abnormalities,
reduction in the cellular gap junction and increase in
motility. They possess inherent growth signals, which
make them resistant to growth suppression signals.
They manifest resistance to apoptosis, a programmed
cell death that is necessary for maintaining the
homeostasis between cell growth and cell death in the
body (Fulda, 2009). These properties of a cancer cell
are possible targets for drug development with a focus
on halting cell growth, invasion and progression.
Over the years, an enormous number of drugs have
been synthesized and used to either prevent or cure
cancer (Cragg and Pezzuto, 2016). However, their
untoward systemic adverse effects on patients, the
rapid development of drug resistance and higher cost
of treatment are some of the drawbacks rendering
them ineffective in overall cancer management. As a
result, despite advances in the development of synthetic
oncogenic drugs, cancer patients are increasingly
dependent on alternative medicines for treatment due
to their safety, availability, affordability, minimal adverse
effects and less chance of developing resistance. Plants
are the only source of medicine in ancient times (Petrovska,
2012; Pan et al, 2014). Surprisingly, they remain a
significant source of medicine till now, predominantly
in developing countries due to their advantages over
commercial synthetic drugs. World Health Organization
(WHO) has reported that about 80% of the world
population still relies on the herbal mode of therapy
than conventional synthetic drugs (WHO, 2014).
Cancer researchers have therefore focused their
attention more on natural products as an alternative
source of cancer control and cure. Ancient Atharva
Veda and Ayurveda of India, Papyrus of Egypt and
traditional Chinese medicine provide rich documentations
of plant-based preventive and curative methods of
ailments and diseases (Lemonnier et al, 2017). Several
parts of plants like stems, barks, roots, leaves, seeds
and their extracts are used as herbal drugs (Li and
Weng, 2017). About 60% of the prescribed anticancer
drugs in use are derivatives of plant metabolites.
Paclitaxel (Pacific yew), camptothecin (Camptotheca
acuminata), vincristine and vinblastine (Madagascar
periwinkle) and etoposide (Podophyllum) or their
water-soluble analogs are some examples of wellknown plant-derived anticancer products (Fridlender
et al, 2015; Howes, 2018). Several other promising
plant natural compounds with anticancer activity and
their modes of action are described in Lichota and
Gwozdzinski (2018).
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Rice serves as a staple food for majority of the world’s
population. Although the content of total phenolics
and flavonoids of black rice and red rice varieties is
higher than the white rice varieties in most cases, some
exceptions are observed (Shen et al, 2009; Chutipaijit
and Sutjaritvorakul, 2018). Rice and its byproducts
such as bran and husk harbor phenolic compounds
(ferulic acid and p-coumaric acid), phytic acid, tocopherols
and tocotrienols, which act as chemopreventive agents
(Tan et al, 2017; Yu et al, 2019).
The synthesis of plant secondary metabolites by
plant tissue culture is independent of environmental
conditions (Smetanska, 2008). Plant cell culture system
offers a unique opportunity for the large scale production
of anticancer compounds due to their industrial level
scalability and the advantage over human and bacterial
cell cultures due to the lack of human pathogens and
bacterial endotoxins (Xu and Zhang, 2014). Several
pharmaceutical proteins including serum albumin and
taliglucerase alfa are produced using carrot, tobacco
and rice cell cultures as well as (Yao et al, 2015).
Although callus cultures have been used to produce
targeted natural products, there is very little information
on the use of plant callus suspension culture as a
cytotoxic or anticancer agent. Callus suspension culture
and callus extracts of rice and desert cotton, respectively
have been shown to be cytotoxic to cancer cells (Deshpande
et al, 2012; Rahman et al, 2016; Kamalanathan and
Natarajan, 2018).
The major objectives of this review were to provide
an update on plant secondary metabolites with
anticancer activity, the use of plant callus suspension
cultures for in vitro production of secondary metabolites
and the potential application of rice callus suspension
culture with secondary metabolites as an anticancer
agent. Further, the biological pathways regulated by
secondary metabolites including those found in rice
callus suspension culture were discussed.
Secondary metabolites and their anticancer
effects
Secondary metabolites are not essential for the growth
and development of plants, but they have important
accessory activities such as help in defense against
herbivory, growth inhibition of competing plants,
bacterial and fungal pathogens and aiding in
pollination. They possess various anti-inflammatory
and anti-oxidant activities (Adebayo et al, 2015).
Anti-oxidant capabilities include termination of free
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radical chains and chelation of redox active metal ions
that cause lipid peroxidation. These properties also
help with cancer prevention. Secondary metabolites of
plants are grouped into alkaloids, terpenoids, polyphenols
and flavonoids based on their structures (Singh et al,
2016). Notable anticancer alkaloids include vinblastine,
vincristine and camptothecin; terpenoids include lycopene
and gamma-tocopherol; polyphenols include etoposide,
resveratrol, curcumin and epigallocatechin gallate
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(EGCG); and flavonoids include apigenin, genistein
and kaempferol. These bioactive compounds exert
anticancer effects either independently or synergistically
with other compounds through regulation of metabolic
and signaling pathways, inhibition of enzymes vital
for cancer progression, angiogenesis, microtubule
assembly and inducing apoptosis (Kojima-Yuasa et al,
2015). Over the years, several plants and plant extracts
are being studied for their antiproliferation properties,

Table 1. In vitro examples of plant bioactive compounds and their molecular targets.
Phytochemical (Source) (Dose)
Apigenin (sorghum) and quercetin
(cowpea) (0.1 μmol/L)

Cancer type

Mode of action and its target

Reference

Caco-2 cell model and non-cancer Activity of efflux transporters in Caco-2 modified by
Agah, 2016
CCD-18Co cell line
inhibiting expression of ABC transporters, BCRP,
MRP2, MRP3 and MDR1
Altholactone (Goniothalamus sp.) LNCaP, PC-3 and DU-145
Inhibited STAT3 and NF-țB transcription
Jiang et al, 2017
(10, 20 and 40 μmol/L)
prostate cancer cells
Curcumin (Curcuma longa)
Colorectal cancer cell lines
Suppressed the Sp-1 activation and its downstream
Chen et al, 2013
(20ௗμmol/L)
genes, ADEM10, calmodulin, EPHB2, HDAC4 and
SEPP1
Fisetin
Hepatic, colorectal and pancreatic Modulated CDK5, glucocorticoid signaling and ERK/
Youns and
(Fragaria ananassa)
cancer cell lines
MAPK signaling, mediated by the activation of
Hegazy, 2017
(1–10 μmol/L)
CDKN1A, SEMA3E, GADD45Į and GADD45ȕ and
down-regulation of TOP2Į, CCNB, KIF20A and
CCNB1 genes
Goniothalamin
HeLa cervical cancer, MCF-7
Induced oxidative stress in cancer cells leading to
Alabsi et al,
(Goniothalamus sp.)
breast cancer and HT-29 colon
apoptosis. Up-regulation of p53 stabilized by NQO1 2012; Seyed et al,
(300 μmol/L)
cancer cells
leading to caspase-2-dependent
2014
mitochondrial-mediated apoptosis
Ursolic acid (Oldenlandia diffusa) Lung cancer
Inhibited the activity of a mitotic kinase,
Kim et al, 2015
(25 μmol/L)
vaccinia-related kinase 1
Ethanolic extract with Avicennones MB-231 cell induced tumor in
Avicennones D and E containing ethanolic extract
Huang et al,
D and E (Avicennia marina) (200
nude mice
treatment decreased MMP2, MMP9, cyclin B,
2016
mg/kg)
vimentin, PARP, caspase 8 and snail protein
expression and increased caspase 3 expression
Curcumin (Curcuma longa)
NSCLC (A549) subcutaneous
Inhibited in vivo tumor growth, adiponectin and MMPs Tsai et al, 2015
(45 mg/kg)
xenograft tumor model
expression
Genistein (Glycine max)
A431 and Colo205 xenografts
Upregulated GLUT3 and downregulated ERĮ
Honndorf et al,
(500 mg/kg)
(mouse)
2016
Clinical trials for colorectal and
Regulated nuclear factor țB (NF-țB) signaling pathway Berman et al,
Resveratrol
prostate cancers
and p53, inhibited IGF-1R/Akt/Wnt and
2017
(Vitis vinifera)
PI3K/Akt/mTOR pathways
(100–1000 mg)
Usnic and salazinic acids
A549 cell induced lung cancer in Activated apoptotic signaling pathway in vitro and
Nguyen et al,
(Flavocetraria cucullata extract)
Balb/c nude mouse
reduced levels of phosphor-Akt
2014
(10 μmol/L usnic acid; 5 μg/mL
extract)
Ursolic acid (Punica granatum)
Postmenopausal breast cancer
Anti-tumor effect through Akt/mTOR signaling
de Angel et al,
(266 mg/kg)
model
2010
Withaferin A
HCT116 colon cancer cells
Anticancer effect mediated by the inhibition of STAT3 Choi and Kim,
(Withania somnifera)
injected into BALB/c nude
signaling pathway
2015
(2 mg/kg)
mouse
ABC transporter, ATP binding cassette transporter; ADAM10, A Disintegrin and metalloproteinase domain-containing protein 10; BCRP, Breast
cancer resistance protein; CCNB, Cyclin B; KIF20A, Kinesin family member 20A; CCNB1, Cyclin B1; CDKN1A, Cyclin dependent kinase inhibitor
1A; CDK5, Cyclin-dependent kinase 5; EPHB2, Ephrin type-B receptor 2; ERK, Extracellular signal-regulated kinase; ERĮ, Estrogen receptor alpha;
GADD45Į, Growth arrest and DNA damage 45 alpha; GADD45ȕ, Growth arrest and DNA damage 45 beta; GLUT3, Glucose transporter 3; HDAC4,
Histone deacetylase 4; IGF-1R, Type-1 insulin-like growth factor receptor; MAPK, Mitogen-activated protein kinase; MDR1, Multidrug resistance
protein 1; MMP2, Matrix metalloproteinase 2; MMP9, Matrix metalloproteinase 9; MRP2, Multidrug resistance protein 2; MRP3, Multidrug
resistance protein 3; mTOR, Mammalian target of rapamycin; NSCLC, Non-small-cell lung carcinoma; NF-țB, Nuclear factor kappa light chain
enhancer of activated B cells; NQO1, NAD(P)H quinone oxidoreductase; PI3K, Phosphatidylinositol-3-kinase; PARP, Poly ADP ribose polymerase;
SEMA3E, Semaphorin-3E; SEPP1, Selenoprotein P1; SP-1, Specificity protein 1; STAT3, Signal transducer and activator of transcription 3; TOP2Į,
Topoisomerase 2-alpha.
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and many of them display potential ability to inhibit
cancer growth and progression (Grothaus et al, 2010).
Table 1 summarizes some investigated plants and their
active components showing prominent cancer preventive
and inhibitory effects. A comprehensive study on the
underlying mechanism of the action of these compounds
and other novel compounds and their interactions can
explain the biological basis of their anticancer effects.
Towards this goal, it is essential to understand the
various changes in cancer physiology that differentiate
it from a normal proliferating cell so that the side effects of
an anticancer agent on normal cells can be prevented.
Biological pathways serving as targets of
plant metabolites
The hallmark of a cancer cell is its uncontrolled rate of
proliferation. A cancer cell alters its physiology to
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meet the nutritional and energy requirements. These
alterations are in the form of modifications in metabolic
pathways, signaling pathways and enzymatic regulation
(Fig. 1). Some of the essentially crucial elements of
these altered metabolic pathways are glucose, glutamine,
oxygen and adenosine triphosphate (ATP) (Biswal et al,
2017). These metabolic alterations mainly focus on
rapid ATP production, synthesis of macromolecules
needed for cell progression and regulation of appropriate
redox state. In case of scarcity of nutrients and energy,
cancer cells are able to modulate their pathways and
continue proliferation. Genetic alterations and tumor
microenvironment contribute to the abnormal phenotype
of cancer. The characteristic changes in metabolism
and pathway can serve as important targets for cancer
therapy. The challenging task is to find a specific
window to differentiate the proliferating cancer cells

Fig. 1. Major players and pathways involved in cancer metabolism and their regulation by plant metabolites.
Curcumin and other plant natural compounds regulating PI3K/Akt/mTOR pathway are shown. Adapted from Porta et al (2014), Eales et al (2016),
and Kastenhuber and Lowe (2017).
Akt, Protein kinase B; C-Myc, Cellular myelocytomatosis; 4E-BP1, Eukaryotic initiation factor 4E binding protein 1; FKBP-12, Drug FK506 binding
protein-12; GLUT, Glucose transporter; HIF-1Į, Hypoxia-inducible factor-1 alpha; mTOR, Mammalian or mechanistic target of rapamycin; OCT1,
Octamer binding transcription factor-1; PDH, Pyruvate dehydrogenase; PDK, Pyruvate dehydrogenase kinase; PKM2, Pyruvate kinase M2; PTEN,
Phosphatase and tensin homolog; PI3K, Phosphatidylinositol-3-kinase; SCO2, Synthesis of cytochrome C oxidase 2; TCA cycle, Tricarboxylic acid
cycle; TIGAR, Tumor protein 53 inducible glycolysis and apoptosis regulator.
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and proliferating normal cells. The advancement of
analytical technology has resulted in the discovery of
numerous cancer signaling pathways and processes
which are specifically regulated in cancer cells and are
important for malignant transformation (Green and
Llambi, 2015). Warburg effect is a significant change
in cancer metabolism, where energy production is
diverted from the normal oxidative phosphorylation to
aerobic glycolysis (Warburg, 1956). This shift serves
two vital purposes: produce ATP rapidly and produce
large quantities of substrate for the biosynthesis of
macromolecules needed for cancer progression. This
diversion to glycolysis makes glucose essential for
cancer cells. It has been reported that glucose transporters
(GLUT) are up-regulated in cancer in a cell-specific
manner (Thorne and Campbell, 2015). Targeting
GLUT presents a viable strategy for cancer inhibition
and treatment. Plant extracts have been shown to target
GLUT. For example, naringenin, a flavonoid presents
in grapes inhibits glucose uptake in MCF-7 breast
cancer cells by inhibiting the phosphoinositide 3kinase (PI3K) pathway that regulates glucose transporter,
GLUT4 (Harmon and Patel, 2004). Another regulator
(inhibitor) of glucose transporter is phloretin, a polyphenol
presents in apple which reduces tumor progression
(Kundu et al, 2014).
The PI3K pathway is a common pathway activated
by mutations in genes whose protein products are
known to modulate processes involved in cancer such
as cell proliferation, motility, metabolism and survival
(Broecker-Preuss et al, 2017). It is inhibited in normal
cells by phosphatase and tensin homolog (PTEN),
which is a tumor suppressor. PTEN has been observed
to be mutated and suppressed in cancer cells, thereby
activating the PI3K pathway. The well-studied downstream
target of the PI3K pathway is AKT1 (protein kinase
B), which mainly regulates glycolytic mechanism of
cancer cells through the allocation of glucose transporters
and activation of glycolytic enzymes. Flavonoids of
various plant extracts and curcumin, a polyphenol
from Curcuma longa, have been reported to target the
PI3K pathway and AKT1 (Mouhid et al, 2017), thereby
hindering uncontrolled cell proliferation associated
with cancer.
The mechanistic target of rapamycin (mTOR) is an
essential pathway for the regulation of cell growth and
proliferation. It is responsible for the synthesis of
proteins and lipids needed for cancer cells in the
presence of sufficient nutrition and energy (Cargnello
et al, 2015). This pathway is activated by AKT (Porta
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et al, 2014). The mTOR pathway can serve as an
effective target for combatting cancer. Curcumin has
been reported to inhibit cancer progression by regulating
the mTOR pathway (Hamzehzadeh et al, 2018).
Hypoxia-inducible factor 1 (HIF1) is an important
transcription factor regulating cancer proliferation,
and is generally activated under hypoxic environment.
It has been reported to be readily activated in cancer
cells even under normoxic environment. In cancer,
mTOR pathway is known to upregulate the expression
of HIF1, which in turn upregulates enzymes involved
in glycolysis as well as glucose transporters (Eales et al,
2016). The hypoxic tumor microenvironment induces
HIF1 activating enzymes to produce energy. HIF1
also activates the expression of gene encoding
vascular endothelial growth factor (VEGF), thereby
promoting angiogenesis (Zimna and Kurpisz, 2015).
Topotecan, a semisynthetic derivative of pentacyclic
alkaloid and camptothecin, which is a metabolite of
the Chinese yew, inhibits HIF1 in cervical cancer
(Robati et al, 2008). Glyceollin, a phytoalexin from
soybean, reduces the expression of HIF1, resulting in
the inhibition of HIF1-induced genes (Lee et al, 2014).
AMP-activated protein kinase (AMPK), the energy
status sensor of the body, is reported to be suppressed
by various signaling pathways and mutations in cancer.
Activation of AMPK can, therefore, serve as a good
target for inhibiting cancer cell proliferation and
growth. AMPK activation leads to cell death in a P53
dependent pathway (He et al, 2014). Oleanolic acid
(OA), a triterpenoid presents in a number of medicinal
plants, is reported to activate AMPK in cancer cells,
which has been shown to suppress the growth of
prostate cancer cell line PC-3 and breast cancer cell
line MCF-7 (Liu et al, 2014). Curcumin has also been
reported to induce apoptosis in ovarian tumor cell via
activation of AMPK (Pan et al, 2008).
P53 is known to be an important tumor suppressor,
which is down-regulated in cancer. In a normal cell, it
detects DNA damage and halts the cell cycle for repair
or diverts the cell to apoptosis through caspase
activation. P53 has been reported to up-regulate TP53induced glycolysis and apoptosis regulator (TIGAR)
(Kastenhuber and Lowe, 2017) and PTEN, thereby
suppressing glycolysis by inhibiting PI3K pathway.
Although it is a known tumor suppressor, P53 is also
involved in modulating the glycolytic phenotype in
cancer by activating the enzyme hexokinase 2, thereby
potentiating the macromolecule synthesis in cancer
through the pentose phosphate pathway (Simabuco et al,
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2018). Several plant metabolites such as curcumin,
resveratrol and quercetin induce apoptosis through the
p53-dependent pathway (Panda et al, 2017). Most of
the cell cycles regulated by p53 are indirect and involve
a repressor complex, dimerization partner, RB-like,
E2F and MuvB (DREAM) (Engeland, 2018). Efficient
chemotherapeutic drugs can be developed by understanding
the mechanisms by which these regulators modulate
the cell cycle. Flavonoids like quercetin, genistein and
flavopiridol have been reported to inhibit cyclindependent kinases (CDKs). Anthocyanins inhibit proliferation
of cancer by blocking progression through the cell
cycle by targeting P53, P21, cyclin D and cyclin A.
Phytic acids from rice bran up-regulate P53 gene in
liver cancer cells (Al-Fatlawi et al, 2014). Gammaoryzanol and tricin from rice bran extracts inhibit
G2/M phase whereas gamma-oryzanol, gamma-tocotrienol
and phytic acid inhibit G0/G1 phase of cell cycle in
cancer cells (Yu et al, 2019). Gamma-oryzanol also
inhibits nuclear factor kappa light chain enhancer of
activated B cells (NF-țB) signaling pathway.
Topoisomerase II is an important enzyme for DNA
replication during cell division. It regulates the negative
supercoiling of DNA downstream of the replication
fork (Ketron and Osheroff, 2014). Topoisomerase
covalently binds with the cleaved DNA forming a
complex which serves as a target for various conventional
anticancer drugs that inhibit cancer cell proliferation.
However, this leads to negative consequences for normal
cells. Genotoxic agents that target this enzyme-DNA
complex are known as ‘topoisomerase poisons’. In
addition, topoisomerase catalytic inhibitors reduce catalytic
turnover of topoisomerase. Well known examples of
eukaryotic topoisomerase II poisons include podophyllotoxin
derivatives (etoposide and teniposide), doxorubicin
and fluoroquinolones (Pommier, 2013). Phytochemicals
such as curcumin, resveratrol, EGCG and isothiocyanates
have also been reported to act as topoisomerase
poisons and catalytic inhibitors.
Lactate dehydrogenase (LDH) which catalyzes the
synthesis of lactate from pyruvate under anaerobic conditions
is vital for cancer cells as it shunts oxidative
phosphorylation to lactate in the hypoxic tumor
microenvironment. LDH-A is one of the two isoforms
of LDH, which converts pyruvate to lactate and is
overexpressed in cancer cells. LDH-A is a downstream
target of HIF1Į, promoting lactic acid fermentation to
generate nicotinamide adenine dinucleotide (NAD+) in
hypoxic conditions that is essential for cancer cell
glycolysis. LDH-A knockdown experiments demonstrated
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activation of the mitochondrial respiratory pathway in
cancer cells, which results in repression of tumor
progression (Miao et al, 2013). Some plant extracts
have been screened to discover their potential in
inhibiting LDH, which can serve as an anticancer
target (Deiab et al, 2014). For example, Rhus chinensis
was discovered to be a potent LDH inhibitor, which
decreases the viability of tumor cells.
Apoptosis pathway is an important target of
plant metabolites
Apoptosis is an energy-dependent programmed cell
death, which maintains the homeostatic balance
between cell proliferation and cell death. Homeostasis
is lost in cancer because the apoptotic mechanism is
suppressed through various mechanisms (Hanahan
and Weinberg, 2011). Many natural anticancer agents
have been shown to induce the apoptotic pathway
directly or activate apoptosis as a final step in the
process. The characteristic features of an apoptotic
cell are cell shrinkage, pyknosis and karyorrhexis
(nuclear fragmentation). There is another passive
process of cell death called necrosis that is energy
independent. A thin line of difference exists between
these two processes. Researchers on various occasions
have found these two processes to be regulated by a
common network of pathways (Nikoletopoulou et al,
2013). The determination of cell death by apoptosis or
necrosis is dependent on the cell death signal, the
developmental stage and the type of cell. Vascular
disrupting agents that disrupt established tumor
vasculature are found to promote the necrotic death of
tumor (Kretzschmann and Furst, 2014).
Apoptosis is grouped into three steps: initiation,
execution and engulfment phases. Each step is regulated
by caspases. Caspases 2, 8, 9 and 10 perform the
initiation phase, and caspases 3, 6 and 7 perform the
execution phase (Green and Llambi, 2015). Once a
single caspase is activated, it initiates a cascade of
activation of other procaspases starting the apoptosis
process. Various plant metabolites that directly
activate either the initiator caspases or the execution
caspases. Quercetin, a well-known flavonoid, induces
apoptosis in cancer cells through the activation of
caspases 3 and 7 (Khan et al, 2016). Luteolin, a flavonoid
found in broccoli, celery and carrots, induces apoptosis
in various cancer cell lines through the activation of
caspases 3, 8, 9 and 10 (Horinaka et al, 2005). Phytic
acids in rice and rice bran have been shown to enhance the
expression of caspases 3 and 8 in colon and liver
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cancer cells (Shafie et al, 2013; Al-Fatlawi et al, 2014).
Rice tocotrienols (gamma/delta) also activate caspase
3, leading to apoptosis in cancer cells (Yu et al, 2019).
Two pathways, extrinsic (death receptor pathway)
and intrinsic (mitochondrial pathway), are responsible
for initiating apoptosis (Fig. 2). Both pathways are
dependent on each other for their regulation and
activation (Pfeffer and Singh, 2018). The activation of
a caspase cascade is a hallmark of apoptosis. The
extrinsic pathway begins with the expression of
various death receptors on the surface of the cells such
as fas ligand (FASL), tumor necrosis factor (TNF) and
tumor necrosis factor related apoptosis-inducing ligand
(TRAIL). These receptors transmit signals from the
surface to the intracellular signaling pathway. Binding
of ligand to these receptors activates procaspase 8.
Plant extracts have been reported to exert an
anticancer effect by increasing the expression of death
receptors on cancer cells. For example, O. majorana
extract, rich in phenolic terpenoids, flavonoids, tannins,
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hydroquinone, phenolic glycosides and triterpenoids,
is found to induce apoptosis via upregulation of
TNF-Į and has been reported to induce apoptosis in
ovarian cancer cells by increasing TRAIL (Yi et al,
2014). Luteolin, a flavonoid found in several plants,
can enhance expression of death receptors and death
receptor downstream factors such as FASL, TRAIL
and fas-associated death domain (FADD) proteins in
HeLa cells (Ham et al, 2014).
The intrinsic pathway is initiated via various
mitochondrial initiated events. These events include
an increase in mitochondrial membrane permeability,
depletion of transmembrane potential and release of
proapoptotic proteins like cytochrome C, second
mitochondria-derived activator of caspases (SMAC)
and serine protease, a high-temperature requirement
protein A2 (HtrA2/Omi) (Pfeffer and Singh, 2018).
These proapoptotic proteins activate procaspase 9 and
apoptotic protease-activating factor-1 (APAF-1). Several
plant metabolites have been reported to initiate apoptosis

Fig. 2. Initiation phase of apoptosis and their regulation by plant metabolites.
Both pathways (extrinsic and intrinsic) result in the formation of an apoptotic body, which is a diagnostic biomarker of apoptosis. Curcumin,
delphinidin and malvidin regulate both intrinsic and extrinsic pathways. Adapted from Kuppusamy et al (2013).
APAF-1, Apoptotic protease activating factor-1; Cyt C, Cytochrome C; FADD, FAS-associated death domain; FASL, Fas ligand; FLIP, FADD-like
Interleukin-1beta-converting enzyme inhibitory protein; TNF, Tumor necrosis factor; TRAIL, TNF-related apoptosis inducing ligand; XIAP, X-linked
inhibitor of apoptosis.
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in cancer cells by mitochondrial perturbations (Cincin
et al, 2015; Green and Llambi, 2015; Zeng et al, 2018).
For example, betulinic acid, a pentacyclic triterpenoid
found in the bark of white-birched trees, activates
apoptotic cell death by decreasing mitochondrial potential
and increasing permeability with no effect on normal
proliferating cells. This characteristic makes betulinic
acid a promising anticancer agent. Quercetin can also
induce apoptosis in DLD-1 colon cancer cell line by
decreasing the mitochondrial membrane potential.
Bcl-2 (B-cell lymphoma 2) family members are rich
in pro- and anti-apoptotic proteins, which mainly regulate
apoptotic processes associated with mitochondria.
Anti-apoptotic proteins include Bcl2, Bcl-x, Bcl-XL
(B-cell lymphoma-extra large) and AKT-1 that inhibit
apoptosis by preventing caspase activation (Green and
Llambi, 2015). Pro-apoptotic proteins include Bcl-10,
Bax (BCL2-associated X protein), Bak (Bcl-2 homologous
antagonist/killer), and Bid (BH3 interacting-domain
death agonist). Phytic acid in rice bran enhances Bax
protein and reduces Bcl-XL protein in colorectal and
liver cancer cells (Shafie et al, 2013; Al-Fatlawi et al,
2014). Quercetin has been documented to induce
apoptosis in cancer cells through the inhibition of
activation of PI3K/Akt/mTOR (Rivera et al, 2016). It
also increases the expressions of Bax, Bad and Bcl-10.
Other pro-apoptotic proteins that initiate apoptosis in a
caspase-independent manner include apoptosis-inducing
factor (AIF) and caspase activated DNase (CAD). Once
released, these proteins are translocated to the nucleus
causing DNA fragmentation, which can initiate the
apoptotic pathway (Green and Llambi, 2015). Some
bioactive compounds of plants, such as magnolol, a
hydroxylated biphenyl, are reported to induce apoptosis
in non-small cell lung cancer by DNA fragmentation
and release of Bid, Bax and cytochrome C.
The execution pathway is the second phase of
apoptosis after the initiation phase. It is activated by
caspases 8, 9 and 10, and mediated by caspases 3, 6
and 7. Execution pathway is characterized by the degradation
of the nuclear particle, nucleus and cytoskeletal proteins.
Caspase 3 on activation inhibits the suppression of
endonuclease CAD by ICAD. CAD on activation
degrades DNA and condenses chromatin. Even though
it is the second important step of apoptosis, no plant
metabolites have been reported to activate the execution
phase of apoptosis in cancer cells.
The final stage of apoptosis is the engulfment of the
apoptotic cell by phagocytes. This is mediated by the
attraction of phagocytes through the externalization of
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phosphatidylserine on the surface of apoptotic cells by
a member of tumor necrosis factor receptor superfamily
6 (FAS), caspase 8 and caspase 3 (Green and Llambi,
2015). Although plant metabolites (berberine, ursolic
acid, malvidin, curcumin, etc.) have been shown to
exert an anticancer effect by apoptosis on various
cancer cell lines by activating the initiation phase, there
is a need for more research to determine the effect of
these compounds on the execution and engulfment
phase of apoptosis. Extensive study to see the effects
of these compounds on normal proliferating cells
should be performed to verify whether the anticancer
effect is efficient for proceeding to clinical trials.
Plant metabolites target angiogenic property
associated with cancer
Pathologically initiated angiogenesis is a hallmark of
cancer. As cancer progresses, cell proliferation exceeds
cell death to a point where tumor cells further away
from blood circulation suffering severe nutrition and
oxygen insufficiency. Tumor cells can overcome the
insufficiency by creating new blood vessels from
existing ones by releasing various factors that directly
or indirectly induce angiogenesis through proliferation
and differentiation of endothelial cells. This phenomenon
is called ‘angiogenic switch’ (Al-Abd et al, 2017). The
angiogenic switch is followed by degradation of extracellular matrix and endothelial migrations. Various VEGF
and angiopoietin (Ang) family members are involved in
the process. Genes encoding VEGF are up-regulated
due to hypoxia and signals from several oncogenes
such as Ras and Myc. VEGF-A is considered to be the
major regulator of angiogenesis which binds specific
tyrosine kinase-like receptors that are upregulated in
various cancers. Several plant metabolites like flavonoids,
tannins, triterpenoids and sulphated carbohydrates
inhibit angiogenesis in cancer cells (Wang et al, 2014).
Polymethoxylated flavonoids in citrus fruits are
shown to have anti-angiogenic activity in cancer cells
(Cirmi et al, 2016). Betulinic acid has been reported to
inhibit aminopeptidase N enzyme that is overexpressed in
various cancers and is involved in the regulation of
angiogenesis (Fulda, 2008). Plant extracts are efficient
vascular disrupting agents of tumors. They can be
subdivided into two classes: ligand directed agents,
which include various antibodies and factors targeting
endothelial receptors, and small molecule agents,
which include various flavonoids and tubulin-binding
agents (Kretzschmann and Furst, 2014).
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Targeting microtubules for cancer prevention
by plant metabolites
Microtubules (MT) are essential structures in the
cytoskeleton of the cell, composed of Įȕ tubulins.
They are involved in cell division and possess various
motility and signaling functions. They help in segregation
of chromosomes and separation into daughter cells
during mitosis. Aberration in their assembly and
function causes abnormal cell division, cell arrest and
apoptosis. These integral functions make them an
important target for inhibiting division of cancer cell.
Agents targeting microtubules in cancer cells can be
divided into two categories: MT-stabilizing and
destabilizing agents (Bates and Eastman, 2017).
Various microtubule-associated proteins (MAP) help
in regulating the dynamics of microtubules which can
serve as a potential target for inhibiting microtubules.
Although synthetic and semi-synthetic derivatives of
plant compounds are currently used to treat cancer,
their anti-proliferative effects on normal cells along
with cancer cells result in detrimental adverse side
effects. These include commercially prescribed cancer
drugs, paclitaxel, vincristine and vinblastine. It has
been hypothesized that derivatization and purification
of plant extract to a single compound make it more
toxic because of no synergistic interactions of different
compounds present in the plant. Plant extracts have
been reported to be more efficient with less toxicity to
normal cells (Iqbal et al, 2017). For instance, Cortex
mori extract has been reported to bind tubulins of
microtubules inhibiting its assembly and ultimately
inducing apoptosis (Nam et al, 2002).
Plant natural compounds in clinical trials
Several plant natural compounds or their derivatives
that do not belong to the classical anticancer compounds
(vinblastine/vincristine, camptothecin, paclitaxel and
podophyllotoxin) are in various stages of clinical trials
(Pan et al, 2012). Hemoharringtonine (alkaloid ester)
is approved for use in the treatment of chronic
myeloid leukemia, especially in patients who are
resistant to the treatment of tyrosine kinase inhibitors
(Seca and Pinto, 2018). Several clinical trials are in
progress as single and combined therapies with
hemoharringtonine for different cancers. Ingenol
mebutate isolated from Euphorbia sp. has been shown
to have cytotoxic as well as immune-modulatory
effects due to loss of mitochondrial membrane potential
(Ogbourne and Parsons, 2014). It has been approved
as a drug for keratosis, a precancerous condition and is
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under phase I/II clinical trials for skin cancer treatment.
Several clinical studies have been conducted with
curcumin and are in progress in combination with other
anticancer drugs due to its role as a chemosensitizer
(Gupta et al, 2013; Seca and Pinto, 2018). Betulinic
acid is a triterpene presents in many plants in low
quantities. Betulin is present in large quantity in birch
bark. It can be converted to betulinic acid which is an
effective anticancer agent against a wide range of
cancer types (Ali-Seyed et al, 2016). Betulinic acid
and combretastatin are in phase I/II clinical trials as
anticancer agents. Indigo (indole alkaloid) derivative
is in a clinical trial for chronic myeloid leukemia. Lycopene
and resveratrol have shown promising results in
clinical trials for prostate cancer and colon cancer,
respectively (Sahin et al, 2017; Alam et al, 2018).
Plant callus suspension culture as a tool for
production of anticancer compounds
Isolation of natural products extracted directly from
plants has limitations such as dependence on the
availability of space, soil and environmental conditions as
well as the effect of extraction and purification
processes on the yield and stability of metabolites.
Moreover, production and isolation of chemicals or
natural compounds from rare or endangered medicinal
plants using conventional techniques from plant parts
are not possible. The initial overexploitation of Taxus
brevifolia for the production of paclitaxel has resulted
in the declaration of the plant as near threatened
(Howes, 2018). The production of secondary metabolites
from plant cells via in vitro techniques under aseptic
conditions has the potential of providing an unlimited
supply of targeted compounds (Veeresham and Chitti,
2013). Plant cell cultures are being used for the
production of not only anticancer compounds but also
biopharmaceuticals including therapeutic antibodies
for other diseases (Efferth, 2019). Callus is an
undifferentiated mass of totipotent cells. Callus
extracts have been reported to give superior results
compared to extracts from plant parts as seen in the
case of Aegle marmelos callus extract which lowered
blood sugar level of diabetic rabbits more efficiently
than leaf extract (Arumugam et al, 2008). Furthermore,
callus extract is shown to be as efficient as leaf extract
of stone apple (Aegle marmelos) and miracle fruit
(Gymnema sylvestre) in lowering blood sugar levels of
diabetic rabbits (Arumugam et al, 2008; Ahmed et al,
2010). Comparison of callus cultures and plant
extracts identi¿ed higher antioxidant activity in callus
cultures (Hakkim et al, 2007). A callus suspension
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culture is made by growing callus in liquid plant
growth medium for three weeks. During this period,
they start releasing their secondary metabolites. The
secondary metabolites could also be part of the cells.
Callus suspension cultures unlike plant parts offer the
advantage of providing an unlimited supply of compounds.
Due to rapid growth cycles of cell suspension cultures,
they are generally used for the large-scale production
of bioactive secondary metabolites such as paclitaxel,
vinblastine and vincristine (Vanisree et al, 2004;
Georgiev and Maciuk, 2009). Plant cell cultures have
been employed for the production of anticancer
compounds, resveratrol from Arachis hypogea callus
culture (Nandagopal et al, 2017). Aralin, a cytotoxic
lectin produced from Aralia elata callus culture shows
2-fold higher activity than the compound isolated from
plant part due to glycosylation (Tomatsu et al, 2004). The
production of an antiproliferative furanoheliangolide
was reported in Lychnophora ericoides callus culture
(dos Santos et al, 2004). Rosmarinic acid and
salvianolic acid B produced from callus culture of the
Chinese medicinal plant, Salvia miltiorrhiza, show
cytotoxic activity against acute lymphoblastic leukemia
(Wu et al, 2016). Rice cell suspension cultures have
been used to produce human Į1-antitrypsin, serum
albumin, lysozyme, interleukin-12 (IL-12) and a
cytokine, granulocyte-macrophage colony stimulating
factor (Xu et al, 2011; Santos et al, 2016). Rice cell
cultures give higher expression of human IL-12 and
lower proteolytic activity compared to other plant
cells (Shin et al, 2010). The high levels of expression
in the rice cell culture system are achieved in most
cases by the use of an inducible rice Į-amylase 3D
(RAmy3D) promoter. The production of specific
compounds in callus cultures can be enhanced by
adding elicitors. This is based on the principle that
plants increase the production of specific secondary
metabolites when subjected to abiotic (drought, salt,
heat, cold and heavy metal, etc.) or biotic (bacteria,
fungi, virus, and nematodes, etc.) stress which act as
external elicitors for inducing gene expression directly
or indirectly. A number of abiotic and biotic elicitors
enhance the production of vinca alkaloids in
Catharanthus roseus cell cultures (Siddiqui et al,
2013). Paclitaxel production increases 2-fold using an
endophytic fungus (Aspergillus niger) of Taxus
chinensis as an elicitor in callus culture of T. chinensis
(Wang et al, 2001). In another study, methyl jasmonate is
found to enhance paclitaxel levels in Taxus baccata
callus suspension culture (Tabata, 2004). The addition
of methyl jasmonate doubles the production of
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shikonin derivatives with antitumor activity in callus
culture of Arnebia euchroma (Hao et al, 2014). The
production of camptothecin in Camptotheca acuminata
cell culture increases 11-fold by UV-B light, and
10-hydroxycamptothecin increases 25-fold by salicylic
acid (Pi et al, 2010).
Plant callus suspension culture as a
promising anticancer agent
There are only a few studies where plant callus
suspension culture or their extracts were evaluated for
their cytotoxic activity. The methanol extract of callus
suspension culture of green tea (Camellia sinensis)
inhibits growth (64%) of the human cervix carcinoma
cell line, HEP-2 (Choi et al, 2006). Two flavones,
echioidinin and 7-O-methywogonin, isolated from the
callus culture of a medicinal plant Andrographis
lineata, show cytotoxicity on a leukemic cell line
(Mohammed et al, 2015). However, this study did not
use the callus culture for cytotoxicity studies. In
another study, the methanol extract of Echinacea
purpurea callus treated with ZnO nanoparticles show
an increase in flavonoid content and cytotoxic activity
on the breast cancer cell line MCF-7 (Karimi et al,
2018). Cytotoxic activity of rice callus suspension
culture (RCSC) was reported for the first time in renal
and colon cancer cell lines where up to 95% decrease
in cell viability was observed with no significant
effect on normal lung fibroblast cell line at specific
dilutions of RCSC (Fig. 3; Deshpande et al, 2012).
Cytotoxic activity of RCSC was found to be as
effective as Taxol but without the side effects of
killing normal cells. Further extension of this study
showed similar effects on lung and breast cancer cell
lines where lung cancer cell lines show better response
compared to the other cancer cell lines (Rahman et al,
2016). The extent of inhibition in cell proliferation by
RCSC in metastatic colon cancer cell line is much
greater than non-metastatic colon cancer cell line. A
differential response was also observed in breast
cancer cell lines where the hormone-dependent cell
line shows a better response to RCSC than the hormoneindependent cell line. It is likely that specific RCSC
compounds may directly or indirectly inhibit the
binding of estrogen to receptors on breast cancer cells.
Molecular and cellular mechanisms involved
in cytotoxic activity of RCSC
Previous studies showed high levels of LDH in cancer
cells, which can be attributed to the Warburg effect
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where high rates of glycolysis drive pyruvate to lactic
acid fermentation. Treatment with RCSC reduces the
total cellular LDH levels about 90% in colon and lung
cancer cell lines, which is a positive attribute for its
anticancer activity (Rahman et al, 2016). RCSCtreated lung cancer cell lines show evidence of
apoptotic changes based on analysis of caspases 3 and
7, which are involved in the execution phase of
apoptosis. RCSC affects membrane integrity of cancer
cells but not normal cells. Real-time PCR analysis
identi¿ed the upregulation of genes involved in apoptosis
and cell cycle inhibition and down-regulation of
cancer-promoting genes. A gene encoding FASLG
protein, which is a member of the tumor necrosis
factor superfamily with a role in apoptosis, is upregulated. A surprising finding is the up-regulation of
a proto-oncogene, c-Jun, which is related to the
PI3K-AKT pathway. Some studies have shown the
role of c-Jun in apoptosis via alternate signaling
pathways involving c-Jun N-terminal protein kinase
(JNK) as demonstrated in the cytotoxic activity of
tylophorine, an alkaloid from the medicinal plant,
Tylophora indica (Andrianantoandro, 2012; Yang et al,
2013). The cytotoxic activity of grape seed extract is
attributed to apoptosis mediated by JNK (Tyagi et al,
2003). The levels of most integrins increase in cancer
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cells due to their roles in tyrosine kinase signaling
which regulates proliferation and adhesion of cells.
However, two integrins, Į2ȕ (ITGA2B) and ȕ3 (ITGB3),
which are expressed at lower levels in cancer cells, are
up-regulated on RCSC treatment. Up-regulation of
ITGB3 is shown to suppress the malignant tumors
(Kaur et al, 2009). The molecular mechanism proposed
for the cytotoxic activity of RCSC is shown in Fig. 4.
Scanning electron microscopy analysis shows flatter
morphology of the cancer cells treated with RCSC,
indicating that they are not at mitosis (Fig. 4; Rahman
et al, 2016). Furthermore, sizes of cells are more
homogeneous than control, suggesting that these cells
are controlled by cell cycle checkpoints. Cells are
better attached to each other, suggesting the possible
alterations of cell junctions.
Double role of RCSC as a cytotoxic and
anti-inflammatory agent
The potential of RCSC to act as an anti-inflammatory
agent was shown in three human normal colon cell
lines by the treatment with proinflammatory cytokines
followed by RCSC (Driscoll et al, 2019). RCSC, its
concentrates and its bioactive fractions not only show
anti-inflammatory activity in an in vitro inflammatory
bowel disease model but also display cytotoxic

Fig. 3. Effects of rice callus suspension culture (RCSC) and Taxol® on normal and cancer cells.
RCSC reduces the viability of cancer cells with minimal or no effect on the normal cells compared to Taxol® based on Deshpande et al (2012) and
Rahman et al (2016).
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Fig. 4. Molecular mechanisms regulating cytotoxic
activity of rice callus suspension culture
(RCSC).
RCSC upregulates the transcription factor,
NF-țB, which induces the production of the
tumor necrosis factor, FASLG, leading to
apoptosis via extrinsic pathway. Up-regulation
of c-Jun leads to downregulation of cyclins and
cyclin-dependent kinases, resulting in apoptosis
via intrinsic pathway. c-Jun has also been
shown to upregulate NF-țB. RCSC increases
ROS levels in cancer cells, leading to DNA
damage and loss of membrane integrity.
CCND3, Cyclin D3; CDK, Cyclin-dependent
kinase; c-Jun, Cellular protooncogene; FASLG,
Tumor necrosis factor ligand superfamily
member 6; NF-țB, Nuclear factor kappa light
chain enhancer of activated B cells; LDH,
Lactate dehydrogenase; ROS, Reactive oxygen
species.

activity on a colon cancer cell line. This is likely due
to the regulation of cross talk and interdependence of
cancer and inflammation/ROS mediated by RCSC.
The transcription factors NF-țB and signal transducer
and activator of transcription 3 (STAT3) are common
regulators of cancer and inflammation (Elinav et al,
2013). In addition to NF-țB, C-C motif ligand 5
(CCL5) and C-X-C motif chemokines (CXCL) which
are common players between cancer and inflammation
are differentially regulated by RCSC based on gene
expression studies. The cross talk between cancer and
inflammation and the concept that chronic inflammation
leads to cancer has resulted in the process of development
of cytokine-based therapies including the use of
monoclonal antibodies targeted against TNF-Į, VEGF
and interleukin-6 (IL-6), and treatment with IL-2 (Qu
et al, 2018). The above approaches have shown hope
significant reduction in inflammation as well as
regression of tumors. The cross talk and the underlying
molecular mechanisms employed by RCSC can be
studied using a 3D cell culture system or organoids
developed from cancer patient tissues which serve as
in vivo models (Baker, 2018).
Unexpected bioactive compounds in RCSC
RCSC isolated fractions employing column chromatography
and HPLC are shown to harbor anti-inflammatory and
cytotoxic activity (Driscoll et al, 2019). The bioactive
fractions of RCSC comprise 4-deoxyphloridzin,
5ƍ-methoxycurcumin, piceid and lupeol (Fig. 3).
4-deoxyphloridzin is a derivative of phloridzin which
is abundant in the apple peel. Phloridzin is shown to
have anti-aging effects in several organisms through



upregulation of antioxidative enzymes and acting
against glycation (Xiang et al, 2011). Phloridzin
inhibits sodium-glucose transporter 1 (SGLT1) and
glucose facilitative transporter 2 (GLUT2) in Caco
cells (Manzano and Williamson, 2010). 4-deoxyphloridzin
in RCSC might inhibit glucose transporters thereby
limiting cancer cells from utilizing glucose as an
energy source. 5ƍ-methoxycurcumin is a natural derivative
of curcumin, which is a well-known anticancer,
antioxidant and anti-inflammatory agent. Piceid is a
glycoside form of resveratrol from which resveratrol
is synthesized naturally. It is abundant in grapes and
red wine among others. Piceid shows tumor cell
cytotoxicity as well as higher radical scavenging
activity compared to resveratrol (Su et al, 2013). The
presence of piceid in RCSC is surprising as rice does
not have piceid or resveratrol but transgenic plants
which produce piceid or resveratrol have been
reported (Baek et al, 2013). Lupeol is a triterpenoid
found naturally in some fruits and vegetables. Lupeol
is an anticancer and anti-inflammatory agent exerting
its effect through NF-țB and PI3K/Akt signaling
(Saleem, 2009). Lupeol has been reported in HPLC
sub-fraction of black rice bran extract which shows
anti-leukemic activity (Suttiarporn et al, 2015). The
enzyme, curcuminoid synthase (CUS), a type III
polyketide synthase, was identified from rice, which
can synthesize bisdemethoxycurcumin in vitro from
coumaroyl-CoA and malonyl-CoA (Katsuyama et al,
2010). The four compounds reported above in RCSC
are produced during the three weeks of incubation
involved in its production and are not present in rice
tissues or callus in significant quantities.
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Popular anticancer compounds, often waterinsoluble, have low bioavailability and short half-life,
which limits their application for cancer treatment
(Fridlender et al, 2015). For instance, paclitaxel and
curcumin are water insoluble. Some natural compounds
have limited absorption in the intestines and liver.
Semisynthetic soluble analogs have been developed to
overcome the above limitations. Further, nanoparticles
and liposomes have been developed as drug carriers
for plant natural products (Karimi et al, 2018; Shishir
et al, 2019). Liposome-mediated treatment with curcumin
enhances cytotoxicity in a skin cancer cell line, breast
cancer cell lines, and human glioma cells transplanted
in mice (Karewicz et al, 2013; Kangarlou et al, 2017;
Zhao et al, 2018). Nanoparticles have been used to
enhance the bioavailability of curcumin, epigallocatechin
gallate (EGCG) and quercetin (Watkins et al, 2015).
For instance, poly (lactic-co-glycolic acid) nanoparticles
enhance bioavailability of curcumin to 5.6-fold and
lipid nanoparticles to 9.4-fold compared to curcumin
alone (Xie et al, 2011; Ji et al, 2016). Similar issues of
bioavailability and short half-life as observed with
curcumin, EGCG and resveratrol may be encountered
with compounds isolated from plant callus suspension
culture.
The best way forward for the use of plant callus
suspension culture and RCSC for anticancer therapy
depends on several factors. If the pharamacological
activity of purified bioactive compounds is lower than
RCSC, semisynthetic analogs of compounds or a
combination of two or more compounds have to be
evaluated along with different drug delivery options.
If none of the above approaches work, the holistic
approach of employing RCSC as an anticancer agent
needs to be evaluated, which is similar to the principle
of Ayurveda, where a mixture of compounds is used
for the treatment of different ailments. An essential
criterion to consider in all of the above approaches is
the presence of cytotoxic activity on cancer cells with
no effect on normal cells.
Large scale production of specific
compounds in callus suspension cultures for
development of drugs for cancer and other
diseases: Drawbacks and challenges
Large scale production of compounds using plant
callus suspension cultures can be achieved by cell line
selection, optimization of culture conditions and use
of elicitors among others (Ochoa-Villarreal et al,
2016). Anticancer compounds which are manufactured by
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companies using plant suspension cultures include
paclitaxel by Phyton Biotech, Germany, berberines by
Mitsui chemicals, and podophyllotoxin by Nippon Oil,
Japan. The design and operation of bioreactors for
commercial production in plant suspension culture
have to consider the cell size, number and shearing
(Wilson and Roberts, 2012). It is also important to
consider the location of the compound(s), cell wall,
vacuole or extracellular so that a suitable strategy can
be designed for its isolation. Similar approaches can
be used for the production of specific compounds
from RCSC and medicinal plant callus suspension
cultures using different elicitors such as chitosan,
ethylene, jasmonate derivatives, sodium chloride and
vanadyl sulfate. If diseases other than cancer respond
to RCSC or medicinal plant callus suspension cultures,
a similar approach described above and bioreactors
can be used for large scale production of bioactive
phytochemicals and callus cultures. Another alternate
method is the upregulation of gene(s) regulating specific
metabolites in callus culture through transgenic approaches.
Mammalian and microbial cells are being used for
the production of biopharmaceuticals at least 20 years
more than plant cell cultures (Santos et al, 2016). This
gave them a distinct advantage with reference to
optimization of strains, culture/fermentation conditions
and design of bioreactors, which results in higher
yield of natural compounds compared to plant cell
cultures. Downstream processing includes releasing cellular
components by breaking cell membranes which may
release biomacromolecules (such as proteases) that
destroy biologically active molecules is a drawback in
using plant cell cultures (Buyel et al, 2015). Upstream
processing includes the design of bioreactors based on
the volume of the culture and the fermentation process
to be used. Continuous fermentation process of
perfusion type is used for plant cell cultures as it is
superior to batch and fed-batch due to its dynamic
nature where fresh media is added with simultaneous
removal of cell free broth. Chemostat method of
continuous fermentation process where broth with
cells is removed accompanied with the addition of
fresh media is also suitable for plant cell cultures. A
major challenge in large scale production of secondary
metabolites is to prevent microbial contamination in
the bioreactor, which can be accomplished by
maintaining sterile conditions and the use of antibiotics, if
needed. The production of other compounds may
inhibit the production of the targeted compound and
its isolation. The required metabolite may be produced
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in low quantities compared to plant parts or it may be
produced in large quantities without any biological
activity. Further, secondary metabolite production is
reduced with the age of the culture. Cells tend to
aggregate in plant cell culture which require constant
stirring often at high speed and may result in cell
damage. There are regulatory issues that need to be
addressed. These include quality control of the
products, animal testing for toxicity analysis and as a
drug followed by clinical trials. Commercial plant cell
culture platforms for the production of drugs are not
widely established due to the above concerns, which
may be alleviated in the future.
Perspectives
Plant compounds show promising prospects in
developing effective drugs in treating cancer. It is
evident that these components function through different
mechanisms such as altering microtubules, inducing
apoptotic signals and inhibiting metabolic enzymes.
These experimental observations can be used to
characterize the inhibitory effects of plant bioactive
compounds on cancer cells. It is essential to distinguish
the fine line between the normal proliferating cells and
cancer cells so that a target can be identified without
damaging normal cell physiology. Plant callus suspension
cultures have the potential to be new frontiers for the
production of compounds with anticancer activity.
Success stories exist for the large sacle production of
paclitaxel, berberines and podophyllotoxin using plant
cell cultures in bioreactors. Plant callus suspension
culture as exemplified by RCSC showed a highly
desirable trait of selective killing of cancer cells.
Although our studies with RCSC on cancer cell lines
are promising, further studies are needed to understand
genes, proteins, metabolites and interactions between
macromolecules responsible for the biological activity
of RCSC. These studies have to be expanded to
animal model followed by clinical trials. The next step
would be to evaluate callus suspension cultures of
various medicinal plants for their anticancer activity.
If callus suspension cultures and its constituents show
the ability to arrest the proliferation of cancer cells
belonging to multiple cancer types with no effect on
the normal cells, it would be a boon for cancer
treatment in the future.
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